Know Your Pressures NYC
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT05992415
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Elevated Blood Pressure
- Glaucoma
- Glaucoma, Suspect
- Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Virtual Automated Navigator Intervention with Health Education — OTHERConsented participants referred for follow-up to in-office appointments from the 10 developments randomized to the Virtual Automated Navigator Intervention with Health Education Arm will receive text messaging support via REDCAP with all aspects of follow-up appointments at either Columbia University Irving Medical Center or Harlem Hospital, specifically appointment scheduling and education about hypertension and/or glaucoma/suspect over a 1 year period.
- Usual Care — OTHERConsented participants referred for follow-up to in-office appointments from the 4 developments randomized to the Usual Care Arm will only be scheduled for their initial appointments at either Columbia University Irving Medical Center or Harlem Hospital. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence. Arm 2 represents a realistic choice available for participants following screening over a 1 year period.
Study Details
Dr. Lisa A. Hark (PI and Study Chair) and an interdisciplinary team have designed "Know Your Pressures NYC" to conduct blood pressure (BP)/glaucoma screenings in adults age 40+ to identify undiagnosed and/or uncontrolled hypertension and/or glaucoma/suspect. For the purpose of this study, individuals will be identified as glaucoma suspects if they have elevated intraocular pressure (IOP) or have features of glaucoma optic neuropathy, as assessed by optical coherence tomography (OCT) and fundus/optic nerve photographs, as interpreted by the masked Reading Center.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2031
- Completion
- Jun 30, 2031
Study Design
- Enrollment
- 7,085 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Arm 1: Virtual Automated Navigator Intervention with Health EducationConsented participants referred for follow-up to in-office appointments from the 10 NYCHA developments randomized to the Virtual Automated Navigator Intervention with Health Education Arm will receive text messaging support with all aspects of follow-up appointments at either Columbia University Irving Medical Center or Harlem Hospital, specifically appointment scheduling and education about hypertension and/or glaucoma/suspect over a 1 year period.
- Active Comparator: Arm 2: Usual CareConsented participants referred for follow-up to in-office appointments from the 4 NYCHA developments randomized to the Usual Care Arm will only be scheduled for their initial appointments at either Columbia University Irving Medical Center or Harlem Hospital. They will not receive enhanced support. Scheduling this initial appointment will allow tracking of adherence. Arm 2 represents a realistic choice available for participants following screening over a 1 year period.
Primary Outcome Measure
Adherence to the Initial In-Office Appointment for those Referred to Ophthalmology and/or Primary Care (Implementation Outcome) [ Time Frame: 1 year ]
Central Contacts
- Lisa A. Hark, PhD, MBA212-342-4586
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center - 622 W. 168th St. Floor 18 | New York | New York | 10032 |
Find similar trials in New York, NY
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pilocarpine Use After Kahook GoniotomyPHASE3 · Recruiting · Montefiore Medical Center · The Bronx, New York
- Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used DevicesRecruiting · State University of New York at Buffalo · Buffalo, New York
- Glaucoma Drainage Device and Endothelial Cell Loss Compare TrialRecruiting · University of Pennsylvania · San Francisco, California